Morihiko Kimura

925 total citations
47 papers, 698 citations indexed

About

Morihiko Kimura is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Morihiko Kimura has authored 47 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 23 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Morihiko Kimura's work include Cancer Treatment and Pharmacology (22 papers), Breast Cancer Treatment Studies (19 papers) and Estrogen and related hormone effects (10 papers). Morihiko Kimura is often cited by papers focused on Cancer Treatment and Pharmacology (22 papers), Breast Cancer Treatment Studies (19 papers) and Estrogen and related hormone effects (10 papers). Morihiko Kimura collaborates with scholars based in Japan, Switzerland and United States. Morihiko Kimura's co-authors include Muneaki Sano, Yasuhiro Yanagita, Harold A. Harvey, A. Hajba, Shigemitsu Takashima, Takeshi Tominaga, Shoshu Mitsuyama, Hideaki Aoyama, Maiko Fujimori and Hiroshi Nakagomi and has published in prestigious journals such as Clinical Cancer Research, Annals of Oncology and Cancer Letters.

In The Last Decade

Morihiko Kimura

43 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morihiko Kimura Japan	16	349	204	191	145	104	47	698
I. E. Smith United Kingdom	12	503 1.4×	403 2.0×	217 1.1×	200 1.4×	137 1.3×	27	848
Alexandre Bodmer Switzerland	14	344 1.0×	259 1.3×	177 0.9×	123 0.8×	107 1.0×	49	692
J. F. R. Robertson United Kingdom	14	313 0.9×	138 0.7×	175 0.9×	110 0.8×	81 0.8×	29	666
Christina Finlayson United States	13	288 0.8×	303 1.5×	153 0.8×	121 0.8×	158 1.5×	29	634
In Ae Park South Korea	12	319 0.9×	241 1.2×	186 1.0×	62 0.4×	93 0.9×	18	605
A McKinna United Kingdom	11	407 1.2×	232 1.1×	255 1.3×	210 1.4×	125 1.2×	14	756
Takaomi Suzuma Japan	17	306 0.9×	256 1.3×	358 1.9×	185 1.3×	160 1.5×	52	885
Hideya Tashiro Japan	12	335 1.0×	220 1.1×	75 0.4×	148 1.0×	105 1.0×	47	559
Dimitrios Tryfonopoulos Greece	12	269 0.8×	119 0.6×	176 0.9×	107 0.7×	55 0.5×	46	627
Luis T. Campos United States	13	441 1.3×	140 0.7×	201 1.1×	77 0.5×	114 1.1×	29	726

Countries citing papers authored by Morihiko Kimura

Since Specialization

Citations

This map shows the geographic impact of Morihiko Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morihiko Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morihiko Kimura more than expected).

Fields of papers citing papers by Morihiko Kimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morihiko Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morihiko Kimura. The network helps show where Morihiko Kimura may publish in the future.

Co-authorship network of co-authors of Morihiko Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Morihiko Kimura. A scholar is included among the top collaborators of Morihiko Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morihiko Kimura. Morihiko Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujii, Takaaki, Jun Horiguchi, Yasuhiro Yanagita, et al.. (2018). Phase II Study of S-1 plus Trastuzumab for HER2-positive Metastatic Breast Cancer (GBCCSG-01). Anticancer Research. 38(2). 905–909. 5 indexed citations

Shien, Tadahiko, Hiroyoshi Doihara, Nobuaki Sato, et al.. (2017). Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study. Cancer Chemotherapy and Pharmacology. 81(2). 269–275. 7 indexed citations

Niikura, Naoki, Morihiko Kimura, Takayuki Iwamoto, et al.. (2011). Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment. Breast Cancer. 20(1). 67–74. 1 indexed citations

Anan, Keisei, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.. (2011). Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study. Breast Cancer Research and Treatment. 128(3). 775–781. 7 indexed citations

Tominaga, T., Izo Kimijima, Morihiko Kimura, et al.. (2010). Effects of Toremifene and Tamoxifen on Lipid Profiles in Post-menopausal Patients with Early Breast Cancer: Interim Results from a Japanese Phase III Trial. Japanese Journal of Clinical Oncology. 40(7). 627–633. 17 indexed citations

Kusama, M., Tadashi Nomizu, Kenjiro Aogi, et al.. (2009). Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer. Breast Cancer. 17(4). 233–240. 17 indexed citations

Kimura, Morihiko, Takeshi Tominaga, Yuichi Takatsuka, et al.. (2009). Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan. Breast Cancer. 17(3). 190–198. 5 indexed citations

Nishimura, Reiki, Takeshi Tominaga, Morihiko Kimura, et al.. (2008). Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial. Anti-Cancer Drugs. 19(9). 911–915. 2 indexed citations

Kimura, Morihiko, Muneaki Sano, Maiko Fujimori, et al.. (2008). Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.. PubMed. 28(2B). 1239–44. 7 indexed citations

10.

Kimura, Morihiko, et al.. (2007). Study of time-course changes in annual recurrence rates for breast cancer: data analysis of 2,209 patients for 10 years post-surgery. Breast Cancer Research and Treatment. 106(3). 407–411. 20 indexed citations

11.

Toi, Masakazu, Toshiaki Saeki, Kenjiro Aogi, et al.. (2005). Late Phase II Clinical Study of Vinorelbine Monotherapy in Advanced or Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes. Japanese Journal of Clinical Oncology. 35(6). 310–315. 29 indexed citations

12.

Kimura, Morihiko, Muneaki Sano, Toshio Tabei, et al.. (2005). [Study of three-weekly docetaxel and weekly trastuzumab treatment in HER 2-overexpressing metastatic breast cancer patients].. PubMed. 32(3). 335–9. 1 indexed citations

13.

Kusama, M., Keisuke Miyauchi, Hideaki Aoyama, et al.. (2004). Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids. Breast Cancer Research and Treatment. 88(1). 1–8. 51 indexed citations

14.

Kimura, Morihiko, et al.. (2003). A Study on Telomerase Activity and Prognosis in Breast Cancer. Medical Oncology. 20(2). 117–126. 18 indexed citations

15.

Maeno, Kazuma, Ken‐ichi Ito, Yoshihisa Hama, et al.. (2003). Mutation of the class I β-tubulin gene does not predict response to paclitaxel for breast cancer. Cancer Letters. 198(1). 89–97. 34 indexed citations

16.

Asai, Gyo, Nobuyuki Yamamoto, Masakazu Toi, et al.. (2002). Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer. Cancer Chemotherapy and Pharmacology. 49(6). 468–472. 13 indexed citations

17.

Kimura, Morihiko, et al.. (2001). Clinicopathological study of unilateral multiple breast cancer. Breast Cancer. 8(3). 202–205. 1 indexed citations

18.

Matsuyama, Yutaka, T. Tominaga, Yoshiaki Nomura, et al.. (2000). Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Annals of Oncology. 11(12). 1537–1543. 54 indexed citations

19.

Tominaga, T., Yoshiaki Nomura, Junji Uchino, et al.. (1998). Cyclophosphamide, Adriamycin, 5-Fluorouracil and High-dose Toremifene for Patients with Advanced/Recurrent Breast Cancer. Japanese Journal of Clinical Oncology. 28(4). 250–254. 3 indexed citations

20.

Kimura, Morihiko. (1990). Obesity as prognostic factors in breast cancer. Diabetes Research and Clinical Practice. 10. S247–S251. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact